Johnson & JohnsonJNJNYSE
Loading
R&D Expense Growth AcceleratingAccelerating
Percentile Rank77
3Y CAGR-21.5%
5Y CAGR-17.8%
Year-over-Year Change
Year-over-year research & development expense growth
3Y CAGR
-21.5%/yr
Quarterly compound
5Y CAGR
-17.8%/yr
Recent deceleration
Percentile
P77
Within normal range
vs 5Y Ago
0.4x
Contraction
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 15.80% |
| Q3 2025 | 4.44% |
| Q2 2025 | 9.02% |
| Q1 2025 | -39.13% |
| Q4 2024 | 6.99% |
| Q3 2024 | 43.95% |
| Q2 2024 | -2.88% |
| Q1 2024 | -20.94% |
| Q4 2023 | 29.97% |
| Q4 2023 | -6.91% |
| Q3 2023 | 7.18% |
| Q2 2023 | -25.28% |
| Q4 2022 | 32.68% |
| Q4 2022 | -5.89% |
| Q3 2022 | -9.06% |
| Q2 2022 | -13.73% |
| Q4 2021 | 37.93% |
| Q4 2021 | 0.82% |
| Q3 2021 | 6.80% |
| Q2 2021 | -21.18% |
| Q4 2020 | 41.97% |
| Q3 2020 | 4.91% |
| Q2 2020 | 4.92% |
| Q1 2020 | -20.17% |
| Q4 2019 | 24.36% |
| Q3 2019 | -2.51% |
| Q2 2019 | -6.72% |
| Q1 2019 | -11.35% |
| Q4 2018 | 28.55% |
| Q3 2018 | -4.96% |
| Q3 2018 | 9.78% |
| Q2 2018 | -33.87% |
| Q4 2017 | 40.62% |
| Q4 2017 | 12.59% |
| Q3 2017 | 10.92% |
| Q2 2017 | -21.59% |
| Q4 2016 | 21.21% |
| Q4 2016 | -3.80% |
| Q3 2016 | 12.47% |
| Q2 2016 | -29.71% |